Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $119.43 | 8 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Collegium Pharmaceutical, Inc. | $69.77 | 5 | $0 (2024) |
| ABBVIE INC. | $21.76 | 1 | $0 (2022) |
| Fidia Pharma USA Inc. | $14.58 | 1 | $0 (2021) |
| Lilly USA, LLC | $13.32 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $13.68 | 1 | Collegium Pharmaceutical, Inc. ($13.68) |
| 2022 | $21.76 | 1 | ABBVIE INC. ($21.76) |
| 2021 | $83.99 | 6 | Collegium Pharmaceutical, Inc. ($56.09) |
All Payment Transactions
8 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/31/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $13.68 | General |
| Category: Opioid Analgesic | ||||||
| 05/31/2022 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $21.76 | General |
| Category: NEUROSCIENCE | ||||||
| 11/11/2021 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $11.85 | General |
| Category: Opioid Analgesic | ||||||
| 08/30/2021 | Fidia Pharma USA Inc. | HYMOVIS (Device) | Food and Beverage | In-kind items and services | $14.58 | General |
| Category: OSTEOARTHRITIS | ||||||
| 08/25/2021 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $16.47 | General |
| Category: Opioid Analgesic | ||||||
| 07/26/2021 | Collegium Pharmaceutical, Inc. | Nucynta (Drug) | Food and Beverage | Cash or cash equivalent | $14.42 | General |
| Category: Opioid Analgesic | ||||||
| 06/16/2021 | Lilly USA, LLC | EMGALITY (Drug), REYVOW | Food and Beverage | In-kind items and services | $13.32 | General |
| Category: Neuroscience | ||||||
| 04/28/2021 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $13.35 | General |
| Category: Opioid Analgesic | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 21 | 1,114 | 6,137 | $517,575 | $104,334 |
| 2022 | 6 | 595 | 3,213 | $356,167 | $152,665 |
| 2021 | 4 | 336 | 1,789 | $200,642 | $87,892 |
| 2020 | 4 | 217 | 805 | $96,354 | $39,630 |
All Medicare Procedures & Services
35 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 97112 | Therapy procedure to re-educate brain-to-nerve-to-muscle function, each 15 minutes | Office | 2023 | 91 | 2,077 | $219,340 | $39,083 | 17.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 81 | 172 | $97,730 | $21,415 | 21.9% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 65 | 209 | $44,178 | $9,536 | 21.6% |
| 96375 | Injection of additional new drug or substance into vein | Office | 2023 | 64 | 674 | $33,505 | $7,338 | 21.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 35 | 35 | $24,555 | $5,422 | 22.1% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 41 | 452 | $19,765 | $4,490 | 22.7% |
| G0283 | Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care | Office | 2023 | 86 | 514 | $19,137 | $3,323 | 17.4% |
| J3415 | Injection, pyridoxine hcl, 100 mg | Office | 2023 | 76 | 302 | $9,350 | $3,217 | 34.4% |
| 96368 | Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion | Office | 2023 | 65 | 207 | $12,855 | $2,878 | 22.4% |
| 95923 | Testing of autonomic (sympathetic) nervous system function | Office | 2023 | 17 | 19 | $7,376 | $1,658 | 22.5% |
| 97032 | Application of electrical stimulation with therapist present, each 15 minutes | Office | 2023 | 37 | 195 | $8,880 | $1,568 | 17.7% |
| 97750 | Test or measurement for functional capacity, each 15 minutes | Office | 2023 | 40 | 44 | $4,730 | $1,024 | 21.7% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 57 | 57 | $3,407 | $927.30 | 27.2% |
| 97016 | Application of blood vessel compression device | Office | 2023 | 65 | 146 | $5,440 | $920.67 | 16.9% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 42 | 44 | $3,594 | $839.96 | 23.4% |
| J3411 | Injection, thiamine hcl, 100 mg | Office | 2023 | 41 | 116 | $890.88 | $231.00 | 25.9% |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | Office | 2023 | 54 | 179 | $728.53 | $180.74 | 24.8% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2023 | 41 | 116 | $547.52 | $123.70 | 22.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 13 | 14 | $359.94 | $117.60 | 32.7% |
| J3480 | Injection, potassium chloride, per 2 meq | Office | 2023 | 62 | 452 | $257.00 | $39.28 | 15.3% |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | Office | 2023 | 41 | 113 | $948.07 | $2.26 | 0.2% |
| 99308 | Follow-up nursing facility visit per day, typically 15 minutes | Facility | 2022 | 371 | 2,767 | $307,137 | $133,001 | 43.3% |
| 99307 | Follow-up nursing facility visit per day, typically 10 minutes | Facility | 2022 | 91 | 247 | $17,537 | $7,461 | 42.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 53 | 85 | $14,025 | $4,970 | 35.4% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 44 | 66 | $7,656 | $3,287 | 42.9% |
About John Ham, PHYSICIAN ASSISTANT
John Ham, PHYSICIAN ASSISTANT is a Physician Assistant healthcare provider based in Shorewood, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/14/2006. The National Provider Identifier (NPI) number assigned to this provider is 1508961376.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, John Ham, PHYSICIAN ASSISTANT has received a total of $119.43 in payments from pharmaceutical and medical device companies, with $13.68 received in 2024. These payments were reported across 8 transactions from 4 companies. The most common payment nature is "Food and Beverage" ($119.43).
As a Medicare-enrolled provider, Ham has provided services to 2,262 Medicare beneficiaries, totaling 11,944 services with total Medicare billing of $384,520. Data is available for 4 years (2020–2023), covering 35 distinct procedure/service records.
Practice Information
- Specialty Physician Assistant
- Location Shorewood, IL
- Active Since 09/14/2006
- Last Updated 05/18/2009
- Taxonomy Code 363A00000X
- Entity Type Individual
- NPI Number 1508961376
Products in Payments
- XTAMPZA (Drug) $55.35
- BOTOX (Biological) $21.76
- HYMOVIS (Device) $14.58
- Nucynta (Drug) $14.42
- EMGALITY (Drug) $13.32
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.